Home 5 Lab Compliance Advisor 5 CLIA-lca 5 Outcome of LDT Regulation Controversy Defies Forecasting

Outcome of LDT Regulation Controversy Defies Forecasting

by | Jul 31, 2015

Few, if any, device regulatory issues are as controversial or as important as FDA’s proposal to regulate Laboratory-Developed Tests (LDTs). If FDA LDT regulation does occur, it would represent the largest change in the regulation of diagnostic tests since Congress enacted the Clinical Laboratory Improvement Amendments (CLIA) in 1988. It would also represent the largest […]

This content is exclusive to Lab Compliance Advisor subscribers

Start a Free Trial for immediate access to this article and our entire archive of over 20 years of LCA reports.